SC 13D Filing

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

July 18, 2002

Accession Number

0001144204-02-000473

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →